FBT
GSK icon

Founders Bank & Trust’s GSK GSK Stock Holding History

Founders Bank & Trust’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$327K Sell
6,113
-131
-2% -$7.33K 0.17% 81
2014
Q3 		$358K Buy
6,244
+646
+12% +$39.6K 0.2% 73
2014
Q2 		$374K Buy
5,598
+148
+3% +$10K 0.21% 70
2014
Q1 		$363K Buy
5,450
+1,448
+36% +$97.9K 0.21% 70
2013
Q4 		$259K Buy
4,002
+1,196
+43% +$77.5K 0.15% 82
2013
Q3 		$176K Buy
2,806
+1,400
+100% +$90.1K 0.09% 90
2013
Q2 		$87K Buy
+1,406
New +$89.2K 0.05% 120

Other funds holding GSK

LTI
Laffer Tengler Investments Nashville, Tennessee $677M AUM 27.58% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Founders Bank & Trust's GSK Position: Q4 2014 in Review

Founders Bank & Trust reduced its GSK (GSK) stake by 2.1% in Q4 2014, selling an estimated $7.33K and leaving 6,113 shares worth $327K. The position accounts for 0.17% of the portfolio, ranked #81.

Founders Bank & Trust first reported a position in GSK in Q2 2013 and has held it in 7 quarters since. The position peaked at $374K in Q2 2014. 728 funds tracked by Wall St. Rank hold GSK as of Q4 2014.

  • Founders Bank & Trust held 6,113 shares of GSK worth $327K as of Q4 2014.
  • Founders Bank & Trust sold 131 GSK shares in Q4 2014, an estimated $7.33K.
  • GSK made up 0.17% of Founders Bank & Trust's portfolio in Q4 2014, its #81 holding.
  • Founders Bank & Trust first reported a position in GSK in Q2 2013 and has held it in 7 quarters since.
  • Founders Bank & Trust's GSK position peaked at $374K in Q2 2014.
  • 728 funds tracked by Wall St. Rank held GSK as of Q4 2014.

Based on Founders Bank & Trust's 13F filing for Q4 2014, filed 9 Feb 2015.